ELAN Elanco Animal Health Incorporated Common Stock Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
23:53
Jun 02
Jun 02
Elanco is top animal health play.
Elanco is preferred over Zoetis in animal health because CEO Jeff Simmons has come on very strong recently.
LOW
20:44
May 07
May 07
Elanco is positioned for durable growth.
Elanco is gaining market share through innovation (six blockbusters, two fastest-growing products), omni-channel distribution, and diversification across farm and pet segments, both domestic and international. The company has guided for mid-single-digit revenue growth, high-single-digit bottom-line growth, and low-double-digit EPS growth, and the CEO is excited about the next 12-14 months. Animal health industry is durable with strong secular tailwinds from protein demand and pet spending.
HIGH
00:50
Feb 25
Feb 25
Elanco reported strong earnings with 12% revenue growth and is gaining market share in parasiticides and dermatology. The "humanization of pets" and the "protein revolution" (increased demand for beef/dairy) are secular tailwinds. Innovation (new drugs like Zenrelli) is driving share gains. A turnaround story that is working; buy for growth. Competition in the animal health space.
About ELAN Analyst Coverage
Buzzberg tracks ELAN (Elanco Animal Health Incorporated Common Stock) across 2 sources. 3 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (100%). 3 total trade ideas tracked. Latest voices: Jim Cramer, Jeff Simmons.